The Braden Scale is a risk stratification tool currently used by nurses to identify patients at risk of developing hospital acquired pressure ulcers (HAPUs). The tool operates on a 23-point system comprised of 6 components (Sensory Perception, Moisture, Activity, Mobility, Nutrition, Friction & Shear) where a threshold value of 18 distinguishes those with "low risk" (19-23 points) from those considered "high risk" (≤18 points). A Braden score is calculated on day of admission and updated throughout the hospital stay. Only patients deemed "high risk" are placed under special nursing protocols aimed at preventing pressure ulcer formation. Using linear regressions analysis, this study sought to better understand factors affecting the timing of HAPU development between high and low risk patients.
PURPOSE:
The Braden Scale is a risk stratification tool currently used by nurses to identify patients at risk of developing hospital acquired pressure ulcers (HAPUs). The tool operates on a 23-point system comprised of 6 components (Sensory Perception, Moisture, Activity, Mobility, Nutrition, Friction & Shear) where a threshold value of 18 distinguishes those with "low risk" (19-23 points) from those considered "high risk" (≤18 points). A Braden score is calculated on day of admission and updated throughout the hospital stay. Only patients deemed "high risk" are placed under special nursing protocols aimed at preventing pressure ulcer formation. Using linear regressions analysis, this study sought to better understand factors affecting the timing of HAPU development between high and low risk patients.
METHODS:
A retrospective cohort study was performed looking at patients with HAPUs over a 2-year period at Yale New Haven Hospital (YNHH). Patients were stratified into two HAPU risk groups based on day of admission Braden score: low risk (>18) or high risk (≤18). A linear regression model analyzed the impact of multiple factors, including Braden Scale components, using the day of pressure ulcer formation during the hospital admission as the dependent variable.
RESULTS:
On a sample of 1,308 HAPU admissions, the average length of stay was 30.8 days (Standard Deviation ± 45.3), and HAPU development occurred on average after 12.7 days (SD ± 16.2). "High risk" patients developed ulcers after 11.2 days (SD ± 18.5) and "low risk" patients developed ulcers after 13.0 days (SD ± 15.8). Among "low risk" patients (Braden score >18), 13.2% still developed HAPUs. Among these patients, a one point decrease in the Sensory Perception component score or Friction & Shear component score was associated with the hastening of pressure ulcer formation by 10 days (p<0.001, Confidence Interval: -15.3--5.87) or 5 days (p<0.04, CI: -9.98--0.24), respectively.
CONCLUSION:
Patients deemed to be "low risk" for HAPU development by Braden score evaluation still carry potentially significant risk for HAPU development and should be monitored closely. Based on our analysis, emphasis should be placed on monitoring closely the Sensory Perception and Friction & Shear components of Braden scores. Decreases in these components, even when the overall Braden score remains higher than 18, should lead to the implementation of special nursing protocols conventionally used for "high risk" patients. Such measures should further decrease the incidence of HAPU formation and improve the quality of hospital care for patients. 
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Opioid Prescribing Consumption Trends in Outpatient Plastic Surgery
Katherine Rose, MD University of Wisconsin, Madison, WI, USA PURPOSE: Opioid over-prescription is a nationwide problem contributing to the current opioid epidemic. Methods to reduce the frequency with which opioids are prescribed are being investigated across multiple disciplines. Currently, there are no data detailing the prescribing habits and need for post-operative narcotics for patients undergoing Plastic Surgery procedures. The goal of this study was to evaluate opioid consumption, physician prescribing practices, and patient satisfaction with post-operative pain control following Plastic Surgery procedures.
METHODS:
Patients who underwent inpatient and outpatient Plastic Surgery procedures were given a postoperative questionnaire inquiring about pain control and medication use. We queried about procedure type, quantity of opioids prescribed and used, day of opioid cessation, opioid refill status, subjective pain scores, concurrent use of non-opioid analgesics, and overall satisfaction with their pain control.
PURPOSE:
In the cleft patient, scarring from prior corrective surgeries along with the anatomic aberrancy in the cleft nose leads to poor predictability of nasal changes after midface advancement. Nasal changes in the non-cleft patient after LeFort I advancement is well documented. Those changes are characterized by an increase in alar base width, tip projection, and nasolabial angle. Conversely, the study of nasal changes in cleft orthognathics is limited.
METHODS:
A retrospective chart review was performed of all patients at a single institution who had a cleft lip/palate undergoing LeFort 1 advancement with pre and postoperative 3-dimensional (3D) photos. With 3D imaging software, pre and postoperative measurements were obtained, facilitating both 2D and 3D analysis of nasal changes.
RESULTS:
Nineteen patients (10 girls, 9 boys) met inclusion criteria. Alar base and flare width both increased significantly (1.3mm, p<0.001; 2.3mm, p=0.003), while both total tip projection and relative tip projection decreased (2.0mm, p=0.001, 3.4mm, p<0.001). In addition, 3D analysis of the nose demonstrated an advancement of the entire nasal complex surface postoperatively (1.0mm, p<0.0005). Unilateral cleft patients had a wider alar base following surgery than bilateral clefts (-4.06Â±3.41, -0.98Â±2.15, p=0.032) . On multiple linear regression, presence of a cinch stitch decreases the nasolabial angle (p=0.024), but increases nasal length (p=0.004). Bilateral cleft morphology decreases total tip projection (p=0.024), but increases 3D nasal change (p=0.028).
CONCLUSION:
There are discrepancies in the nasal changes that occur after Lefort I advancement between the cleft and non-cleft population, primarily regarding projection and rotation of the tip. Although the entire nasal surface is advanced postoperatively, tip projection is reduced and rotation limited, potentially indicating scar burden as a significant contributor to changes in nasal aesthetics after cleft orthognathic surgery.
